I wonder if a breakthrough therapy application will go to the FDA in relation to PM. As Jon said the results well exceeded their expectations.
BT is designed to expediate development of drugs "intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s)"
https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy
Ann: 2023 Results webinar, page-69
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.73 |
Change
-0.280(1.33%) |
Mkt cap ! $2.647B | |||
| Open | High | Low | Value | Volume |
| $20.87 | $21.19 | $20.70 | $6.213M | 297.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5414 | $20.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.79 | 335 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.73 |
Change
-0.280 ( 1.22 %) |
||||
| Open | High | Low | Volume | ||
| $20.99 | $21.19 | $20.69 | 94423 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| NEU (ASX) Chart |